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Introduction: Despite progress in reconstructive techniques, rebuilding portions of the thorax remains challenging,
in particular when large resections, contamination or infection are involved. No other cases of thoracic
reconstruction in trauma patients with biological prosthesis have been described since now.
Methods: We report a case of thoracic reconstruction in highly infected field in a trauma patient. We also
performed a literature review about the topic.
Conclusion: Collamend® demonstrated its usefulness in thoracic wall reconstruction even in trauma patients and
infected fields.
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Introduction
Thoracic wall (TW) reconstruction involves different
surgical specialties as oncologic, plastic or trauma sur-
geon. Despite progress in reconstructive techniques,
rebuilding portions of the thorax remains challenging, in
particular when large resections, contamination or infec-
tion are involved. The successful reconstruction must
preserve thoracic wall stability and respiratory function,
eliminate dead spaces, avoid or reduce the risk of infec-
tion and protect the underlying viscera [1, 2]. Indications
for full thickness resection of thoracic wall are primary
thoracic tumors, extensive extra-thoracic neoplastic dis-
eases, congenital aplasia or traumatic events [3-5].
Beyond anatomical repair with soft tissue flaps and
plastic surgery techniques many different prosthetic
materials have been used for TW reconstruction. Poly-
propylene, polyester, expanded polytetrafluoroethylene
(PTFE) and polyethylmethacrylate sandwiched between
layers of polypropylene have been used [6]. In the last
15 years innovative materials have been introduced.* Correspondence: federico.coccolini@gmail.com
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reproduction in any medium, provided the orBiological meshes comprised of several different materi-
als: partially remodeling prosthesis are made of porcine
dermal collagen (PDC), human dermal collagen (HDC),
and bovine pericardium collagen (BPC). Completely re-
modeling prostheses are made of swine intestinal sub-
mucosa (SIS), HDC and BDC. The partially remodeling
prostheses are optimal in TW or abdominal reconstruc-
tion because of they resist better to mechanical stress.
They are physically modified with cross-linkages be-
tween the collagen fibers which strengthen them [7, 8].
In trauma surgery it often happens to stabilize thoracic
wall injuries. Different techniques have been reported
with different devices. The main challenge in trauma
surgery is the potential contamination or the infection of
the surgical field. One of the main characteristic of bio-
logical materials is the possibility to be used safely in
contaminated or infected fields.
Biological prostheses have already demonstrated their
usefulness and versatility in many fields [9-15]. However
as the main part of literature is composed by case series
and case reports, they still require more evidence-based
data [16]. Recently a decisional model about the use of
these mesh have been proposed by the Italian Biological
Prosthesis Work Group [17]. In the last years the Italianal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Italian Register of Biological Prosthesis (IRBP). Also the
European Hernia Society, in the European Register of
Biological Prosthesis (ERBP) is recruiting cases of bio-
logical meshes implanted all around Europe [16].
Materials and methods
We report a case of TW reconstruction with Bard
CollaMend® (Davol, Cranston, RI) in a patient victim of
trauma.
A retrospective review was conducted of all reported
cases of use of biological prosthesis in TW reconstruc-
tion in trauma published up to September, 2012 on




No other reports exist about the TW reconstruction in
trauma with biological prosthesis.
Case report
A 47 years old male transported to the Emergency dept.
of our hospital after a car crash. At the arrive in ER the
patient was shocked with a bi-lateral pneumothorax,
multiple rib fracture (II-III-IV-V-VI) with flail-chest on
the right side (Figure 1), haemo-peritoneum and an
exposed fracture of the right femur. Bilateral thoracic
drains were immediately positioned and the patient was
then transferred to the theatre for an explorative laparot-
omy and liver packing. Two days after the packing have
been removed and the flail-chest (III and IV ribs) was
fixed with titanium devices. The femur fracture was tem-
porarily treated with external fixator. Ten days after the
intervention the postoperative course was complicated
by a biliary fistula treated with ERCP and biliary endo-
prosthesis positioning. During the ICU recovery theFigure 1 Pre-operative CT-scan.patients developed ARDS and chest wound infection.
Blood samples and chest wound cultures demonstrated
infection by Aspergillus Fumigatus and Pseudomonas
Aeruginosa MRSA respectively. The antibiotic treatment
have been immediately addressed. 21 days after the
intervention the patient have been re-operated for
hemorrhagic shock from erosion of the right internal
mammary artery by the rib margin. Surgical haemostasis
was necessary. Free segment of the III and IV ribs were
removed. Due to the infection titanium devices were
removed too and the defect (7×8 cm) was repaired using
a biologic mesh (CollaMend®, 18×23 cm) fixed to the
thoracic wall with PDS-0 interrupted suture (Figure 2).
9 days after the second intervention a thoracic-abdominal
CT-scan was performed (Figure 3). It documented no
thoracic pathologic findings, satisfactory post-surgical
results and a left hepatic artery post-traumatic pseudo-
aneurism treated with angio-embolization. Femur fracture
was then definitively treated with endomidollar pin posi-
tioning. Chest wound infection was treated with medica-
tion and healed completely in four weeks (Figure 4).
18 months after the discharge the patient is well and with
documented no respiratory impairment.
Discussion
The majority of patients were treated for TW reconstruc-
tion after surgical debulking procedure for thoracic mal-
ignancies or for extended abdominal tumors which
interested the chest wall. TW reconstruction is a real chal-
lenge for thoracic surgeons as well. The reconstructiveFigure 2 Reconstruction scheme with biological prosthesis.
Figure 3 CT-scan 9 days after the reconstruction; the red arrow
indicates the prosthesis.
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demonstrated wound infection. Biologic materials are spe-
cially indicated in potentially contaminated or contami-
nated surgical fields [18]. Their resistance to the proteases
activity either bacterial either human is demonstrated.
Moreover they have the unique characteristic to promote
the early revascularization of the regenerate tissue. This
allows to antibiotics to early reach the infected zone and
by reducing the bacterial possibilities to create biologic
niches as in synthetic prosthesis it favors the infection
healing. A mild inflammatory response to these materials
encourages active tissue deposition and natural cytokine
production with a consequent healing process and tissue
repair. As organized tissue deposition occurs, bio-scaffold
is gradually remodeled by host, yielding a repaired tissue
structure that is entirely host derived [14, 19, 20].
The challenge in TW reconstruction is the complex
mechanisms involved in respiration. It implies muscular
and elastic forces whom combined work results in theFigure 4 The complete healed thoracic wound.respiratory equilibrium. It briefly consists in a mild
intra-thoracic negative pressure. A prosthetic material
have to maintain this equilibrium constant to allow the
patient to breath. It also has to avoid at the same time
the air passage through the prosthesis preventing the
subsequent pneumo-thorax. The alteration of the re-
spiratory equilibrium results in either obstructive or re-
strictive impairment. Thoracic reconstructive materials
must have either enough rigidity to allow the thorax to
move symmetrically either elasticity to be able to adapt
to the thorax movement. When a big portion of TW
have to be removed and consequently many ribs lack,
the reconstruction process risks to create an additional
respiratory death space. Some reconstructive methods
insert metal devices to guarantee the necessary rigidity.
However if infection is suspected or demonstrated the
insertion of a foreign body becomes a risky procedure.
In infected fields two are the possibilities: anatomic re-
construction with flap transposition or the use of biolo-
gics. The use of synthetic materials have been widely
described with very good results, but in our opinion is
very risky in potentially contaminated or infected fields.
Reported side effects of synthetic materials include sec-
ondary wound infection in up to 6% of cases, seroma
formation, insufficient tensile strength with respiratory
failure, long-term onset of restrictive lung disease, graft
dehiscence, chronic pain, hemorrhage and wall deform-
ities in pediatric patients [3, 21-23]. As counterpart, the
experience in TW reconstruction with biologics is lim-
ited. Their use is progressively increasing and giving
good results [24]. No other cases have been reported in
literature of thoracic reconstruction in trauma patients.
However in selected cases such a kind of materials could
offers a very trustworthy alternative. The present case
demonstrated the possibility to treat infections also by
multi-resistant bacteria with the contemporary implant-
ation of a biologic mesh. The described case was very
challenging for the necessity to repair TW and the im-
possibility to implant foreign body. The Pseudomonas
Aeruginosa MRSA infected wound, in fact reduced the
therapeutic options. The patients needed a procedure as
shorter and as less invasive as possible. He could hardly
tolerate a long TW reconstructive procedure as in elect-
ive patients.
If biologics demonstrated to have usefulness proper-
ties, as counterpart the main obstacle to their use is the
cost. It is absolutely higher than synthetic mesh, and in
patients without infected or, at least potentially contami-
nated field the use of biologics have not a clearly stated
rationale.
Conclusions
Collamend® demonstrated its usefulness in thoracic wall
reconstruction even in trauma patients and infected
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native to synthetic materials either in reconstructive
thoracic surgery. However dedicated studies from high
experienced centers are needed.
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